Introduction
Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors of the digestive tract with various clinical and biological characteristics. The concept of what constitutes a GIST has been changing due to the advent sigmoid colon cancer. We retrospectively examined these images and we were able to calculate the doubling time of the tumor accurately. By using NIH image software (ver 1.6.0, by Wayne Rasband; National Institutes of Health, Bethesda, MD, USA), the tumor volume was measured as 63.2 cm 3 in September 2000, and as 558.4 cm 3 in July 2001 (Fig. 3A,B) . The doubling time of this tumor was calculated as 3.3 months, which suggested a high growth rate and malignancy.
In August 2001, laparotomy was conducted. A 10-cmsized hard tumor, showing extraluminal growth from the greater curvature of the middle body of the stomach, was covered by the greater omentum (Fig. 4A) . Partial gastric resection was performed. The patient recovered uneventfully and was transferred to a nearby hospital 7 days after the surgery.
Macroscopically, the specimen was a 9.0 ϫ 8.5 ϫ 5.5-cm-sized solid tumor, and the cut surface showed partial necrotic change (Fig. 4B) . We also measured the tumor volume after fixation, by an in-water sedimentation method. The tumor volume was 510 cm 3 , indicating the accurate determination of tumor volume with computed tomographic volumetry. Microscopically, the tumor consisted of spindle-shaped cells with oval nuclei, and there were 15 to 16 mitoses per 50 high-power fields (HPFs), which indicated its malignant nature (Fig. 5) . In immunohistochemical studies, the tumor was positive with respect to c-kit, CD34 (Fig. 6A,B) , and vimentin, but negative with respect to smooth muscle actin and S-100 protein. Concerning the growth rate, 25.5% of the tumor cells were positive for Ki-67 antigen (MIB-1) in the most active area (Fig. 7) . The final pathological diagnosis was malignant GIST.
The patient was found to have hepatic metastasis 27 months after the surgery, and he received hepatic subsegmentectomy in December 2003.
Discussion
Until quite recently, mesenchymal tumors of the gastrointestinal tract had generally been diagnosed as leiomyoma or leiomyosarcoma, based on microscopic findings [18] . The concept of gastrointestinal stromal tumor (GIST) has been changing with immunohistochemical and molecular technical advances [1, 2] . Recently, it has been widely accepted that GIST is a mesenchymal tumor which expresses c-kit oncoprotein or has a mutation in either the c-kit or the plateletderived growth factor receptor-alfa (PDGFRA) gene [2, 3] .
Several studies have revealed various types of c-kit mutations, including mutations in the juxtamembrane domain (exon 11), extracellular domain (exon 9), and tyrosine kinase domain (exons 13 and 17) [4] [5] [6] [7] [8] [9] . Some authors have reported a correlation between the c-kit mutations and poor prognosis in patients with GISTs [4, 5] , but others have reported no such correlations [8, 9] .
Because the definition of GIST has been changed within a short time, there has been uncertainty con- [10] and Ma et al. [11] ) proposed a standard of malignancy associated with the size of the tumor and the number of mitoses. They classified gastric stromal tumors into three groups: (1) benign (Ͻ5 cm in size and Ͻfive mitoses/50 HPFs), borderline (Ͼ5 cm and Ͻfive mitoses/50 HPFs), and malignant (Ͼfive mitoses/50 HPFs). According to this classification, our case was classified in the malignant group. Iwashita et al. [12] reported that cellularity, type of growth, and clinical findings concerning the tumor (for example, necrosis, hemorrhage, and ulceration) were all useful in determining its malignancy. A proliferation index such as the MIB-1 index can be used for assessing prognosis [13] [14] [15] [16] [17] . Carrillo et al [13] reported that a high MIB-1 index (Ͼ22%, in the most active area) was the most powerful predictor of poor survival. The highest MIB-1 index value for the present patient was 25.5%, suggesting the malignant nature of the tumor. Rudolph et al. [14] , Miettinen et al. [15] , Panizo-Santos et al. [16] , and Hasegawa et al. [17] noted that a mean proliferation index of more than 10% was highly predictive of a poor A B prognosis. Past research concerning leiomyoma/leiomyosarcoma has also been useful, because many tumors of smooth-muscle origin would be diagnosed as GISTs in a narrow sense today.
There have been only a few reports concerning the doubling time of gastric submucosal tumors, and the diagnostic criteria could be different for different authors (Table 1) [19] [20] [21] [22] . In 1968, Peck [19] reported that the doubling time in a case of leiomyosarcoma was 4.8 months. After that, Shimamoto et al. [20] calculated the mean doubling time as 44.9 months (range, 20.3-103.0 months) for leiomyoma, and 7.9 months (range, 0.8-18.1 months) for leiomyosarcoma. They advocated that surgical procedures should be implemented in cases that showed a doubling time of less than 20 months. Hamada et al. [21] estimated the mean doubling times as 36.0 months (range, 8.1-95.1 months) for leiomyoma and 7.7 months (range, 4.2-12.6 months) for leiomyosarcoma, respectively. Recently, Kimata et al. [22] reported that the doubling times in two cases of gastric GIST were 11.3 and 1.3 months.
In previous studies, the doubling time was calculated on the basis of barium meal results, assuming that the tumor was spherical. In the present patient, the tumor volume and the doubling time were calculated by computed tomographic volumetry, and the accuracy of the method was shown by comparison with the resected specimen. The calculated results showing a 3.3-month doubling time, indicated a high growth rate, and hence the tumor was categorized as malignant (Table 1) . Actually, this patient was found to have hepatic metastasis 27 months after surgery, and he received a hepatic subsegmentectomy.
To date, there have been no clear standards for the preoperative assessment of GIST malignancy. Routine endoscopic biopsy samples rarely contain tumor components. Endoscopic bore biopsy and needle biopsy under endoscopic ultrasound seem to be useful for tumor assessment, but there is some risk of bleeding. Aspiration biopsy under extracorporeal ultrasound may induce peritoneal dissemination of malignant cells. We usually use clinical indices such as tumor diameter, tumor site, hemorrhage, and ulceration in assessing GIST malignancy. Many GISTs do not have clinical symptoms, and are often incidentally detected in the course of mass screenings or follow-up examinations for In conclusion, we presented a case of gastric GIST. The doubling time of this tumor was accurately calculated by using computed tomographic volumetry. The calculated doubling time was 3.3 months, which indicated a high growth rate and malignancy. Partial gastric resection was performed, and the histological examination confirmed the preoperative assessment done by computed tomographic volumetry. Hepatic metastasis was found 27 months after surgery.
